Instil Bio
31 hedge funds and large institutions have $45.9M invested in Instil Bio in 2024 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 13 reducing their positions, and 4 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 2 → 4 (+2)
53% more capital invested
Capital invested by funds: $30M → $45.9M (+$15.8M)
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
4.71% more ownership
Funds ownership: 60.64% → 65.35% (+4.7%)
3% more funds holding
Funds holding: 30 → 31 (+1)
69% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
BML Capital Management
Zionsville,
Indiana
|
+$3.82M |
| 2 |
BlackRock
New York
|
+$257K |
| 3 |
Renaissance Technologies
New York
|
+$139K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$36.5K |
| 5 |
Barclays
London,
United Kingdom
|
+$5.25K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$201K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$141K |
| 3 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$132K |
| 4 |
Squarepoint
New York
|
-$115K |
| 5 |
Two Sigma Advisers
New York
|
-$80K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Wells Fargo
San Francisco,
California
| $335 | – | – | – |
|
|
FFA
27
Frazier Financial Advisors
Columbus,
Ohio
| $162 | +$164 | +15 | New |
|
28
Osaic Holdings
Scottsdale,
Arizona
| $140 | – | – | – |
|
29
Citigroup
New York
| $22 | – | – | – |
|
30
Bank of America
Charlotte,
North Carolina
| $11 | -$11 | -1 | -50% |
|
31
Qube Research & Technologies (QRT)
London,
United Kingdom
| $11 | +$11 | +1 | New |
|
|
AFM
32
Anson Funds Management
Dallas,
Texas
| – | -$132K | -17,344 | Closed |
|
33
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$1K | -156 | Closed |
|
TIL Hedge Fund Activity: Q1 2024 in Review
31 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Instil Bio (TIL) for Q1 2024, worth a combined $45.9M — up 53% from $30M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new TIL positions and 4 closed out — a net gain of 1 holder — while 4 added to existing stakes and 13 trimmed.
The largest buyer was BML Capital Management, opening a new position worth an estimated $3.82M. The largest seller was Millennium Management, cutting an estimated $201K.
- 31 institutional investors held Instil Bio (TIL) as of Q1 2024, up from 30 in Q4 2023.
- Funds reported $45.9M of Instil Bio stock for Q1 2024, up 53% quarter-over-quarter.
- 5 funds opened new Instil Bio positions in Q1 2024 and 4 closed out, a net change of +1 holder.
- The largest Instil Bio buyer in Q1 2024 was BML Capital Management, an estimated $3.82M added.
- The largest Instil Bio seller in Q1 2024 was Millennium Management, an estimated $201K sold.
Based on aggregated 13F filings for Q1 2024.